HC Wainwright Issues Optimistic Estimate for KYMR Earnings

Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) – Equities researchers at HC Wainwright increased their Q2 2025 earnings per share estimates for Kymera Therapeutics in a research report issued on Monday, May 12th. HC Wainwright analyst A. Fein now antic…

Read Full Article →